Diminished Ovarian Reserve Expert Releases Tip Sheet for Timely Infertility Diagnosis for Young Women
March 07, 2012 (New York, NY) – Center for Human Reproduction (CHR), a leading New York fertility center specializing in fertility treatment for women with diminished ovarian reserve (DOR), has issued a fertility tip sheet for young women with DOR. Younger women with DOR often spend months or even years before receiving the correct diagnosis, resulting in significant delays in appropriate fertility treatments.“Detecting DOR is not difficult,” says Dr. Gleicher, Medical Director and Chief Scientist of CHR. He continues: “Ovarian reserve can be easily measured by simple blood tests, like follicle-stimulating hormone (FSH) and anti-Müllerian hormone (AMH). High FSH and/or low AMH suggest a diagnosis of DOR but both need to be assessed in an age-specific way.”
However, many fertility centers, unused to treating younger women with premature ovarian aging (POA; a term coined by CHR to describe younger women with DOR), often overlook this condition. “They overlook the diagnosis,” explains Dr. Gleicher, “because they do not utilize age-specific cut off values for FSH and AMH.”
Normal FSH ranges increase and normal AMH ranges decrease as women age. If all women of all ages are assessed with universal cutoff values, younger women will never be diagnosed in timely fashion. “Unfortunately,” says Dr. Gleicher, “this is what is still done in many fertility centers.”
Once diagnosed with POA, like older women, women with POA have little time to lose since there is no telling how quickly their POA will progress. Though very rapid progression is rare, according to Dr. Gleicher, CHR physicians have seen women go into full menopause in a few short months after diagnosis.
Dr. Gleicher continues: “There isn’t a day when we don’t hear our patients say ‘doctor, I wish I’d known about your center months ago, when I was doing such and such...’ The earlier we can start treatment, the better, of course, our chances of helping our patients with POA!”
CHR’s tips for younger women with POA to receive timely diagnosis and treatment include the following:
• Be very skeptical of the pseudo-diagnosis of “unexplained infertility.” Especially in younger women, this diagnosis only means that a diagnosis of POA was missed.
• Insist on age-specific ovarian reserve testing with FSH and AMH.
• If your age-specific FSH and/or AMH values are abnormal before age 40, you likely suffer from POA.
• If that is not clearly spelled out to you, your physician may have little experience with diagnosis and treatment of POA, and it may be time for a second opinion.
• Remember that with a diagnosis of POA, time is crucial, because nobody can predict how quickly your ovarian reserve will further decline.
About Center for Human Reproduction
Center for Human Reproduction, or CHR (http://www.centerforhumanreprod.com), is a leading fertility center in the United States with a worldwide reputation as a "fertility center of last resort," specializing in treatment of infertility in women with diminished ovarian reserve, including younger women with premature ovarian aging (POA) and older women with physiological ovarian aging. Dr. Gleicher is available for additional comments.
CHR - New York
21 E. 69th Street
New York, NY 10021
Phone:(212) 994-4400
Fax:(212) 994-4499
webadmin@thechr.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diminished Ovarian Reserve Expert Releases Tip Sheet for Timely Infertility Diagnosis for Young Women here
News-ID: 213510 • Views: …
More Releases from Center for Human Reproduction
IVF Success Rates Not Improved by Preimplantation Genetic Screening, According t …
There is no evidence that recent technical improvements in preimplantation genetic screening (PGS) improve IVF pregnancy chances, according to a paper just published online in the Journal of Assisted Reproduction and Genetics1. The review, by two fertility specialists from New York’s Center for Human Reproduction (CHR), raises important questions, as this “new” PGS is actively marketed to patients as “proven” and “established” to increase IVF success rates.
In the late ‘90s,…
Research from CHR Offers Hope for Women with Treatment-Resistant Thin Endometriu …
November 15, 2012 (New York, NY) – Direct perfusion of the endometrial cavity with granulocyte colony-stimulating factor (G-CSF) improves the thickness of the endometrial lining in IVF patients with too thin endometrium even after treatments, according to a new study just published online in the medical journal Human Reproduction(1).
In the study, 21 women undergoing in vitro fertilization (IVF) cycles at the Center for Human Reproduction (CHR) in New York City…
FMR1 Gene May Control Women’s Fertility Life Cycle, According to Research
October 23, 2012 (New York, NY) – A new study presented at the Annual Meeting of the American Society for Reproductive Medicine (ASRM) in San Diego, CA, offers further evidence that the fragile X mental retardation 1 gene (FMR1 gene) may play an important role in controlling women’s fertility life cycles.
The study, conducted by researchers from the Center for Human Reproduction (CHR), a leading fertility center in New York…
BRCA1/2 Mutation and FMR1 Gene Study Has Potential Implications for Cancer Scree …
BRCA1/2 gene mutations, widely associated with breast and ovarian cancer risks in women, are, in principle, lethal to human embryos, according to new research conducted by three teams of researchers from the Center for Human Reproduction (CHR) in New York City, the Medical University Vienna in Vienna, Austria, and the Medical University Graz, Graz, Austria. BRCA1/2-positive embryos will only survive when also carrying a specific FMR1 gene genotype.
In a paper…
More Releases for POA
Paramagnetic Oxygen Analyzer (POA) Market Sales Status and Forecast Worldwide by …
Global Paramagnetic Oxygen Analyzer (POA) Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables…
Geon – The 4th Fastest Growing dApp in the world, is launching its first IEO o …
June 10, 2019 – Gibraltar - Geon Network Limited (“Geon”, “Geon Network” or “Company”), www.geon.network, is launching the first phase of its IEO program on June 25, 2019, with Nauticus (www.nauticus.io), Australia’s fastest growing regulated Cryptocurrency Exchange and Blockchain ecosystem, with active users in over 84 countries.
Launched to the public officially in October 2018, Geon allows users from around the world to explore over 1,500,000 interesting places…
Geon – The 4th Fastest Growing dApp in the world, is launching its first IEO o …
June 10, 2019 – Gibraltar - Geon Network Limited (“Geon”, “Geon Network” or “Company”), www.geon.network, is launching the first phase of its IEO program on June 25, 2019, with Nauticus (www.nauticus.io), Australia’s fastest growing regulated Cryptocurrency Exchange and Blockchain ecosystem, with active users in over 84 countries.
Launched to the public officially in October 2018, Geon allows users from around the world to explore over 1,500,000 interesting places…
Cancer/Tumor Profiling Market Witnesses Robust Growth in Diverse Industries Eval …
Cancer profiling is a technique used to classify tumors more accurately, which helps in predicting the patient’s clinical outcome. Cancer/Tumor profiling helps in identification of genomic alteration, which aid to select an appropriate therapy for the treatment of cancer. This technique reduces the trial and error process in diagnosis of cancer at various stages and provide more precise and accurate information about clinical outcomes of cancer. Different tests are used…
Cancer/Tumor Profiling Market Witnesses Robust Growth on Back of Increasing Appl …
Cancer profiling is a technique used to classify tumors more accurately, which helps in predicting the patient’s clinical outcome. Cancer/Tumor profiling helps in identification of genomic alteration, which aid to select an appropriate therapy for the treatment of cancer. This technique reduces the trial and error process in diagnosis of cancer at various stages and provide more precise and accurate information about clinical outcomes of cancer. Different tests are used…
Center for Human Reproduction More Than Doubles IVF Pregnancy Rates in Women Ove …
Center for Human Reproduction (CHR), a New York fertility center with special expertise in treating women with “older-behaving” ovaries, reported significantly improved ongoing clinical pregnancy rates for 2011 at practically all age groups. The improvement was, however, most pronounced in women above age 44 years, where the rate doubled from the previous year.
Pregnancy rates are calculated by dividing the number of clinical pregnancies by that of embryo transfers. While most…